Skip to content

Autoimmune Polyglandular Syndrome Type 1 With Reversible Metaphyseal Dysplasia C2749602

Published: July 22, 2026Updated: August 20, 2026

A rare genetic syndrome combining autoimmune endocrine disorders with bone growth abnormalities in children. Usually appears in early childhood. Treatment includes hormone replacement and bone health monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(endocrine)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endocrine management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Hormone replacement therapy

Comprehensive replacement of deficient hormones including parathyroid hormone, adrenal hormones, and pancreatic hormones as indicated by testing.

medication
3

Calcium and vitamin D supplementation

Supplemental calcium and active vitamin D to maintain bone health and address metaphyseal dysplasia while supporting reversible bone changes.

medication

Additional treatment options

Skeletal rehabilitation program

Targeted physical therapy to support bone healing, improve mobility, and prevent deformity during recovery from metaphyseal dysplasia.

physical_therapy

Bisphosphonate therapy

Bone-resorptive medications to support bone density and structural integrity when osteoporosis or osteopenia is present.

medication

Radiographic monitoring

Regular imaging to assess metaphyseal dysplasia resolution and bone structure recovery through X-rays or DEXA scans.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autoimmune Polyglandular Syndrome Type 1 With Reversible Metaphyseal Dysplasia C2749602?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Perheentupa J, Miettinen PJ. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy: A Model Disease for Understanding Primary Autoimmunity. Endocr Rev. 2019.

review2019
2

Husebye ES, Anderson MS, Kampe O. Endocrine Society Clinical Practice Guideline: Management of Autoimmune Polyendocrinopathies. J Clin Endocrinol Metab. 2021.

guideline2021
3

Betterle C, Garelli S, Coco G, Buratto G. Long-term Follow-up and Outcomes in Autoimmune Polyglandular Syndrome Type 1: A Longitudinal Cohort Study. Front Endocrinol. 2020.

clinical_trial2020
4

Ferrara F, De Luca C, Ruggiero G, Chermat F. Skeletal Manifestations in Autoimmune Polyglandular Syndrome Type 1: Reversible Metaphyseal Dysplasia and Bone Health Considerations. Bone. 2022.

review2022

Medication Comparisons

Compare medications used to treat Autoimmune Polyglandular Syndrome Type 1 With Reversible Metaphyseal Dysplasia C2749602. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy